Subjects confirmed to have malignant solid tumors by histopathological examination
Conditions
Interventions
GP-01:68Ga-FAPI-GP01
GP-02:68Ga-FAPI-GP02
Sponsors
Affiliated Hospital of Guilin Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.The subject or their legal representative is able to voluntarily sign the informed consent form. 2.Adult subjects (aged 18-80 years), regardless of gender. 3.Commitment to comply with the study procedures and cooperate throughout the entire study. 4.Subjects confirmed to have malignant solid tumors by histopathological examination. 5.Subjects agree to use contraception for at least 28 days following the administration of 68Ga-FAPI.
Exclusion criteria
Exclusion criteria: 1.The subject or their legal representative is unable or unwilling to sign the informed consent form. 2.Unable to comply with the full study procedures. 3.Pregnant or breastfeeding women. 4.Individuals deemed unsuitable for inclusion by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SUVmax; | — |
Countries
China
Contacts
Public ContactFu Wei
Affiliated Hospital of Guilin Medical University
Outcome results
None listed